Fatal drug-drug interaction of brivudine and capecitabine

Acta Oncol. 2009;48(4):631-3. doi: 10.1080/02841860802660502.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adverse Drug Reaction Reporting Systems
  • Aged, 80 and over
  • Antimetabolites, Antineoplastic / administration & dosage
  • Antimetabolites, Antineoplastic / adverse effects
  • Antimetabolites, Antineoplastic / metabolism*
  • Antimetabolites, Antineoplastic / pharmacokinetics
  • Antiviral Agents / administration & dosage
  • Antiviral Agents / adverse effects
  • Antiviral Agents / metabolism*
  • Antiviral Agents / pharmacokinetics
  • Bromodeoxyuridine / administration & dosage
  • Bromodeoxyuridine / adverse effects
  • Bromodeoxyuridine / analogs & derivatives*
  • Bromodeoxyuridine / metabolism
  • Bromodeoxyuridine / pharmacokinetics
  • Capecitabine
  • Colorectal Neoplasms / complications
  • Colorectal Neoplasms / drug therapy*
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / adverse effects
  • Deoxycytidine / analogs & derivatives*
  • Deoxycytidine / metabolism
  • Deoxycytidine / pharmacokinetics
  • Drug Interactions
  • Drug-Related Side Effects and Adverse Reactions
  • Fatal Outcome
  • Female
  • Fluorouracil / administration & dosage
  • Fluorouracil / adverse effects
  • Fluorouracil / analogs & derivatives*
  • Fluorouracil / metabolism
  • Fluorouracil / pharmacokinetics
  • Herpes Zoster / complications
  • Herpes Zoster / drug therapy*
  • Humans
  • Switzerland

Substances

  • Antimetabolites, Antineoplastic
  • Antiviral Agents
  • Deoxycytidine
  • brivudine
  • Capecitabine
  • Bromodeoxyuridine
  • Fluorouracil